Company Sector Amount (in Type Financing Ownership Name Million of Stage USD) Round Twist Bioscience Corp. Biotechnology / R&D Services CMAB BioPharma

Transcription

1

2

3

4

5

6 Company Sector Amount (in Type Financing Ownership Name Million of Stage USD) Round Twist Bioscience Corp. Biotechnology / R&D CMAB BioPharma Biotechnology / R&D (Suzhou) Macrolide Biotechnology - Pharmaceuticals, 10xBio Biotechnology - Allogene Therapeutics, Zosano Pharma, Axonics Modulation Technologies, Biotechnology - Biotechnology Other Other Series B / n/a Other n/a 2.66 Series A / Equity - Startup Series A / Equity - Startup Other Post-IPO Publicly listed Medical Technology Other Other BIOM'UP Medical Technology Other Other Publicly listed Poseida Biotechnology Series B / Equity - First Therapeutics, stage Surgivisio Medical Technology Series B / Equity - First stage Rezolute, Biotechnology Other n/a Publicly listed CorWave SA Medical Technology 3.50 Other Other Noveome Biotechnology Other Research Biotherapeutics grants Country China (Mainland)

7 Concord Medical (CMS) Holding Limited Biotechnology / R&D UD-00 n/a Publicly listed RefleXion Medical Medical Technology Series C / Equity - 3. Round Second stage Arvinas Biotechnology Series C / Equity - 3. Round Second stage DNA Script Biotechnology / R&D 5.50 Other Research grants Apricus Biosciences, Oxford Endovascular Ltd Eidos Therapeutics Biotechnology Other Post-IPO Publicly listed Medical Technology 3.01 Series A / Equity - Startup Biotechnology Series B / Equity - First stage Delivra Corp. Pharma 1.24 UD n/a Publicly listed Constellation Biotechnology UD n/a Pharmaceuticals, Magenta Biotechnology Series C / Equity - Therapeutics 3. Round Second stage Beijing Biocytogen Biotechnology / R&D Series C / n/a Co., Ltd. 3. Round Promethera Biotechnology UD n/a Biosciences S.A./N.V. Zucara Biotechnology UD n/a Therapeutics FIMECS, Biotechnology UD Equity - Seed Cellectis SA Biotechnology Other Other Publicly listed Mimetas BV Biotechnology / R&D Series B / Equity - Startup China (Mainland) United Kingdom Canada China (Mainland) Belgium Canada Japan Netherlands

8 Pharnext SAS Biotechnology Other n/a Publicly listed RubrYc Biotechnology Series A / Equity - Startup Therapeutics, Tessa Therapeutics Biotechnology Other Other Pte Ltd Sollis Therapeutics Biotechnology Series A / Equity - Startup Enterprise Biotechnology Series B / n/a Therapeutics Ltd. Intec Pharma Ltd. Biotechnology Other Post-IPO Publicly listed BerGenBio ASA Biotechnology Other Other Publicly listed CohBar, Biotechnology Other Other Publicly listed PolarityTE, Medical Technology Other Post-IPO Publicly listed Vineti, Medical Technology Series B / Other Intact Vascular, Medical Technology Series C / n/a 3. Round Promaxo, Medical Technology 2.20 Series A / Other Shuwen Biotech Co.,Ltd. Vicarious Surgical BlueRock Therapeutics Tetherex Pharmaceuticals Inc Biotechnology / R&D 0.00 Series A / Medical Technology Series A / n/a Other Biotechnology Other n/a Biotechnology Series B / Equity - First stage Singapore United Kingdom Israel Norway China (Mainland)

9 Medical Microinstruments S.p.A. Opiant Pharmaceuticals, Grid Therapeutics, LLC BenevolentAI Medical Technology Series A / Other Biotechnology Other Research Publicly listed grants Biotechnology Series B / n/a Biotechnology / R&D Other Other Italy United Kingdom Inventiva SA Biotechnology Other Other Publicly listed Oasmia Biotechnology Other Post-IPO Publicly listed Pharmaceutical AB Atrin Biotechnology Other Research Pharmaceuticals grants ReviveMed Biotechnology / R&D 1.50 Other Equity - Seed Bellicum Biotechnology Other Post-IPO Publicly listed Pharmaceuticals, Inocucor Biotechnology - other Series B / Other Technologies Marrone Bio Biotechnology - other Other Post-IPO Publicly listed Innovations, Apellis Biotechnology Other Post-IPO Publicly listed Pharmaceuticals, Surface Oncology Biotechnology UD n/a Publicly listed NuProbe, Biotechnology / R&D Series A / Equity - Startup Sweden Canada Spectral Medical Medical Technology 5.30 UD Post-IPO Publicly listed Canada

10 Acerus Pharmaceuticals Corporation Pharma 1.59 Other Convertible loan Publicly listed Synpromics Ltd. Biotechnology / R&D 0.30 Other Other Cedilla Biotechnology Series A / Equity - Startup Therapeutics Revolution Biotechnology Series B / Equity - First Medicines, stage Erydel SpA Biotechnology Other Other X-Biotix Biotechnology Series A / Equity - First Therapeutics, stage Corvidia Biotechnology Series B / Equity - First Therapeutics stage Rallybio LLC Biotechnology Series A / Equity - Startup ADC Biotechnology Biotechnology / R&D 1.63 Other Other Ltd. Canada United Kingdom Italy United Kingdom Sangamo Therapeutics, Biotechnology Other Other Publicly listed 10X Genomics Biotechnology / R&D Other Debt financing V-Wave Ltd. Medical Technology Series C / Other 3. Round 10X Genomics Biotechnology / R&D Series D / Equity - Later 4. Round stage Cardiac Medical Technology Series B / Equity - Dimensions, Second stage Israel Kodiak Sciences Biotechnology Other Other

11 DisperSol Technologies, LLC Biotechnology Other Other A-Mansia Biotech Biotechnology - other Series A / Equity - Seed Curetis AG Biotechnology / R&D 4.95 Other n/a Publicly listed DiaMedica Biotechnology Other Other Publicly listed Therapeutics, Spark Therapeutics, Biotechnology Other Other Publicly listed Synthorx, Inc Biotechnology / R&D Series C / Equity - Later 3. Round stage Belgium Germany Attenua, Inc Biotechnology Series A / Equity - Startup Cardionomic, Inc Medical Technology 9.00 Other Other NovellusDx Ltd. Biotechnology / R&D 6.00 Other Other Israel Eagle Genomics Ltd. Biotechnology / R&D 1.00 Other Other United Kingdom

12